Massimo Bonucci | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Prof. Dr. Massimo Bonucci | Medicine and Dentistry | Best Researcher Award

Humanitas Consortium University - ARTOI Foundation | Italy

Prof. Dr. Massimo Bonucci is a distinguished researcher whose scholarly contributions span integrative oncology, cancer therapeutics, and complementary medical approaches. With 153 citations from 153 documents, 20 published documents, and an h-index of 8, his scientific work reflects a growing influence in evidence-based integrative cancer research. His publications demonstrate a strong focus on combining conventional oncology with complementary modalities to enhance patient outcomes, as seen in studies addressing glioblastoma survival, integrative management of myeloproliferative neoplasms, and the synergistic effects of natural compounds such as curcumin, polydatin, and epigallocatechin gallate. His research portfolio includes influential articles in journals such as Journal of Clinical Medicine, Cancers, Onco, Journal of Integrative and Complementary Medicine, and the International Journal of Integrative Oncology, covering topics from locoregional hyperthermia to hematologic diseases, qualitative patient-care insights, and global initiatives in integrative oncology. Recent works explore advancements in dietary supplements, hyperthermia applications, patient-centered care strategies, and international collaborations within the integrative oncology community. Through his continuous contributions and multidisciplinary perspective, Prof. Dr. Bonucci has helped expand the scientific foundation of integrative oncology, supporting its development as a complementary framework within modern cancer research.

Profiles : Scopus | Orcid

Featured Publications

Andreazzoli, F., Yurkovski, I. L., Gowin, K., & Bonucci, M. (2025). Management of myeloproliferative neoplasms: An integrative approach. Journal of Clinical Medicine.

Bonucci, M., Fuggetta, M. P., Anelli, L., Giannarelli, D., Fiorentini, C., & Ravagnan, G. (2025). New approach for enhancing survival in glioblastoma patients: A longitudinal pilot study on integrative oncology. Cancers.

Fiorentini, G., Sarti, D., Mambrini, A., Mattioli, G., Bonucci, M., Ginocchi, L., Cristina, G., Ranieri, G., Bonanno, S., Milandri, C., et al. (2025). Locoregional hyperthermia in cancer treatment: A narrative review with updates and perspectives. Onco.

Bonucci, M. (2025). Superior oral bioavailability of epigallocatechin gallate from TèPigal 300®, a dietary supplement versus a cup of green tea. Journal of Clinical Medical Research.

Stylianou, K., Fuller-Shavel, N., Ghelman, R., Ben-Arye, E., Bonucci, M., Jia, L., Narayanan, S., & Rao, S. (2025). Bridging borders in integrative oncology: A global initiative by the Society for Integrative Oncology. Journal of Integrative and Complementary Medicine.

Bonucci, M. (2025). Introduction to hematologic diseases and integrative therapies: The use of natural supplements and complementary therapies with clinical and preclinical evidence. Figshare.

Chiarlone, P. (2024). Words are life: Written memories in the hospice experience—A qualitative study. International Journal of Integrative Oncology.

Serafino, A., Krasnowska, E. K., Romanò, S., De Gregorio, A., Colone, M., Dupuis, M. L., Bonucci, M., Ravagnan, G., Stringaro, A., & Fuggetta, M. P. (2024). The synergistic combination of curcumin and polydatin improves temozolomide efficacy on glioblastoma cells. International Journal of Molecular Sciences.

Mazzotti, E. (2024). Physical activity in the treatment of cancer patients: An online survey for Italian oncologists and radiotherapists. International Journal of Integrative Oncology.

Mazzotti, E. (2024). Letter to editor on: A feasibility study for the acceptability of virtual reality for patients with cancer undergoing treatment. International Journal of Integrative Oncology.

Cracolici, F. (2024). Improving the quality of life of breast cancer patients with integrated medicine techniques. International Journal of Integrative Oncology.

Anelli, L. (2024). Case report of possible abscopal effect in a patient with metastatic bladder cancer treated with radiotherapy and Artemisia compounds. International Journal of Integrative Oncology.

Giovanni Smaldone | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Book of Award

Dr. Giovanni Smaldone | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

IRCCS Synlab SDN | Italy

Dr. Giovanni Smaldone is a highly accomplished researcher whose work spans molecular biology, structural biochemistry, oncology, immunology, and advanced diagnostic technologies. With 1,037 citations, 83 published works, and an h-index of 18, his contributions reflect both productivity and strong scientific impact. His research integrates structural biology, NMR spectroscopy, molecular interactions, and translational oncology, with a particular emphasis on childhood acute lymphoblastic leukemia (ALL). He has led and contributed to numerous funded research projects, including competitive grants focused on long non-coding RNAs, epigenetic markers, and the KCTD protein family in pediatric leukemia. His studies also extend into protein delivery systems, nanogels, cellular imaging, and biobank development for rare pediatric disorders. Dr. Smaldone’s recent publications highlight advancements in 3D refractive index tomography for leukemia cell analysis, targeted drug-delivery platforms, diagnostic biomarkers such as circular RNAs and LINC00958, and the structural mechanisms underlying KCTD–Cullin 3 interactions. His work frequently appears in high-impact journals across molecular sciences, biomedical engineering, nanotechnology, and clinical research. Additionally, he has presented widely at national and international scientific conferences, contributing to knowledge dissemination in cellular biophysics, protein structure, pediatric oncology, and advanced molecular diagnostics.

Profiles : Scopus | Orcid

Featured Publications

Bianco, V., Pirone, D., Schiavo, M., Bianco, V., Miccio, L., Memmolo, P., Smaldone, G., Pecoraro, G., Altieri, F., Salvatore, M., et al. (2026). Quantitative mapping of leukemia cells and intracellular lipid droplets using 3D refractive index tomography in flow cytometry. IEEE Journal of Selected Topics in Quantum Electronics.

Pizzella, M., Accardo, A., Mercurio, F. A., Sibillano, T., Gallo, E., Morelli, G., Smaldone, G., Giannini, C., Leone, M., Balasco, N., et al. (2025). Structural and functional characterization of self-assembling fragments identified from the transthyretin amyloid-like structure. Nanoscale.

Leone, I., Costabile, V., Smaldone, G., Franzese, M., Soricelli, A., & D’Agostino, A. (2025). Arthrospira platensis attenuates endothelial inflammation and monocyte activation. International Journal of Molecular Sciences.

Gallo, E., Smaldone, G., Cimmino, L., Braile, M., Orlandella, F. M., Luciano, N., Accardo, A., & Salvatore, G. (2025). Fmoc-FF nanogel-mediated delivery of doxorubicin and curcumin in thyroid cancer cells. Pharmaceutics.

Balasco, N., Esposito, L., Smaldone, G., Salvatore, M., & Vitagliano, L. (2024). A comprehensive analysis of the structural recognition between KCTD proteins and Cullin 3. International Journal of Molecular Sciences.

Bianco, V., Wang, Z., Brancato, V., Coppola, L., Smaldone, G., D’Aiuto, M., Mossetti, G., Maffettone, P. L., Salvatore, M., & Ferraro, P. (2024). Adaptive space-time digital holography for imaging flow cytometry and tissue slide analysis. In Digital Holography and Three-Dimensional Imaging (DH 2024).

Coppola, L., Grimaldi, A. M., Sarnacchiaro, G., Di Fasano, M. S., Smaldone, G., & Salvatore, M. (2024). An overview of Synlab SDN Biobank’s quality control system. Scientific Reports.

De Martino, L., Mirabelli, P., Quaglietta, L., Ferrara, U. P., Picariello, S., De Gennaro, D. V., Aiello, M., Smaldone, G., Aliberti, F., Spennato, P., et al. (2024). Biobank for craniosynostosis and faciocraniosynostosis: A study protocol. Child’s Nervous System.

Bianco, V., Valentino, M., Pirone, D., Miccio, L., Memmolo, P., Brancato, V., Coppola, L., Smaldone, G., D’Aiuto, M., & Mossetti, G. (2024). Classifying breast cancer and fibroadenoma tissue biopsies using fractal biomarkers in Fourier ptychographic microscopy. Computational and Structural Biotechnology Journal.

De Martino, L., Mirabelli, P., Quaglietta, L., Ferrara, U. P., Picariello, S., De Gennaro, D. V., Aiello, M., Smaldone, G., Aliberti, F., Spennato, P., et al. (2024). Correction: Biobank for craniosynostosis and faciocraniosynostosis. Child’s Nervous System.

Gallo, E., Diaferia, C., Smaldone, G., Rosa, E., Pecoraro, G., Morelli, G., & Accardo, A. (2024). Fmoc-FF hydrogels and nanogels for improved and selective delivery of dexamethasone in leukemic cells. Scientific Reports.

Gallo, E., Diaferia, C., Smaldone, G., Rosa, E., Pecoraro, G., Morelli, G., & Accardo, A. (2024). Fmoc-FF hydrogels and nanogels for improved and selective delivery of dexamethasone in leukemic cells. Research Square.

Filomena, A., Smaldone, G., Ginevra, S., Santiago, N., Di Fasano, M. S., Peppino, M., Alessandra, C., Antonia, D. M., Giuliana, B., Rosanna, P., et al. (2024). Identification of a circular RNA isoform of WASHC2A as a prognostic factor for high-risk pediatric B-ALL. Biomedicine & Pharmacotherapy.

Raymundo, J. R., Zhang, H., Smaldone, G., Zhu, W., Daly, K. E., Glennon, B. J., Pecoraro, G., Salvatore, M., Devine, W. A., Lo, C. W., et al. (2024). KCTD1/KCTD15 complexes control ectodermal and neural crest cell functions. Journal of Clinical Investigation.

Altieri, F., Buono, L., Lanzilli, M., Mirabelli, P., Cianflone, A., Beneduce, G., De Matteo, A., Parasole, R., Salvatore, M., & Smaldone, G. (2024). LINC00958 as a diagnostic and prognostic biomarker of childhood B-cell acute lymphoblastic leukemia. Frontiers in Oncology.

Vishal Srivastava | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Book of Award

Dr. Vishal Srivastava | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Cleveland Clinic | United States

Author Profile

Orcid

Google Scholar

Early Academic Pursuits 🎓

Dr. Vishal Srivastava’s journey in academia began with a strong foundation in his chosen field of study. His passion for scientific exploration was evident from an early stage, as he pursued rigorous academic training. Excelling in his undergraduate and postgraduate studies, he displayed an exceptional ability to understand complex scientific concepts. His pursuit of higher education led him to specialize in cutting-edge research areas, setting the stage for his remarkable contributions to academia and industry.

Professional Endeavors 💼

With a solid academic background, Dr. Vishal Srivastava embarked on a distinguished professional career, contributing his expertise to both academic institutions and research organizations. Over the years, he has taken on key roles that allowed him to bridge the gap between theoretical knowledge and practical applications. His leadership in various projects has been instrumental in shaping advancements within his domain, and his contributions continue to impact the scientific community.

Contributions and Research Focus 🔬

Dr. Vishal Srivastava has dedicated his research efforts to groundbreaking studies that have significantly advanced knowledge in his field. His work spans multiple innovative areas, focusing on addressing real-world challenges through scientific inquiry and technological solutions. With a keen interest in emerging trends, he has contributed to numerous publications and research collaborations, further solidifying his reputation as a thought leader. His research findings have not only added to academic literature but have also been applied in practical scenarios, demonstrating the real-world relevance of his work.

Accolades and Recognition 🏆

Dr. Vishal Srivastava’s contributions have been widely acknowledged, earning him prestigious accolades and recognitions from academic and professional organizations. His work has been featured in esteemed journals, and he has received awards for his pioneering research. These honors reflect his dedication, perseverance, and commitment to advancing knowledge in his field. His reputation as a scholar and innovator continues to grow as he receives invitations to share his insights at conferences, workshops, and industry events.

Impact and Influence 🌍

Beyond his research and professional achievements, Dr. Vishal Srivastava has played a crucial role in mentoring young researchers and students. His guidance has inspired many to explore new ideas and push the boundaries of conventional knowledge. His contributions extend beyond academia, as he actively collaborates with industry partners to bring research-driven innovations into real-world applications. Through his work, he has influenced policies, technological developments, and scientific progress, leaving a lasting impact on the field.

Legacy and Future Contributions 🚀

Dr. Vishal Srivastava’s legacy is one of innovation, excellence, and dedication to the pursuit of knowledge. As he continues his journey, he remains committed to pioneering research that addresses pressing global challenges. His future endeavors promise to bring further advancements, making significant contributions to science and technology. Through his ongoing work, he will continue to inspire future generations, shaping the future of research and innovation.

Publications

  •  📄Cell-Based Small-Molecule Screening Identifying Proteostasis Regulators Enhancing Factor VIII Missense Mutant Secretion
    Journal: Biomolecules
    Year: 2025
    Authors: Vishal Srivastava, Zhigang Liu, Wei Wei, Yuan Zhang, James C. Paton, Adrienne W. Paton, Tingwei Mu, Bin Zhang

  •  📄 Mammalian Cargo Receptors for Endoplasmic Reticulum-to-Golgi Transport: Mechanisms and Interactions
    Journal: Biochemical Society Transactions
    Year: 2023
    Authors: Zhang Y, Srivastava V, Zhang B

  •  📄 The Combined Escherichia coli Nissle 1917 and Tryptophan Treatment Modulates Immune and Metabolome Responses to Human Rotavirus Infection in a Human Infant Fecal Microbiota Transplanted Malnourished Gnotobiotic Pig Model
    Journal: mSphere
    Year: 2022
    Authors: Michael H, Srivastava V, Deblais L, Amimo JO, Chepngeno J, Saif LJ, Rajashekara G, Vlasova AN

  •  📄 Obese Children Gut Microbiota Influences Inflammatory Mucosal Immune Pathways in the Respiratory Tract to Influenza Virus Infection: Optimization of an Ideal Duration of Microbial Colonization in a Gnotobiotic Pig Model
    Journal: Microbiology Spectrum
    Year: 2022
    Authors: Renu S, Deblais L, Patil V, Schrock J, Kathayat D, Srivastava V, Feliciano-Ruiz N, Han Y, Ramesh A, Lakshmanappa Y S, Ghimire S, Dhakal S, Rajashekara G, Renukaradhya G J

  •  📄 Evaluation of Novel Quorum Sensing Inhibitors Targeting Autoinducer 2 (AI-2) for the Control of Avian Pathogenic Escherichia coli Infections in Chickens
    Journal: Microbiology Spectrum
    Year: 2022
    Authors: Helmy Y A, Kathayat D, Deblais L, Srivastava V, Closs G, Tokarski IIR J, Ayinde O, Fuchs J R, Rajashekara G

 

Jeong A Kim | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Prof. Jeong A Kim | Medicine and Dentistry | Best Researcher Award

St. Vincent Hospital, The Catholic University of Korea | South Korea

Author Profile

Scopus

Early Academic Pursuits ✨

Prof. Jeong A Kim embarked on an illustrious academic journey in the field of medicine, laying a solid foundation at the Catholic University Medical College. She completed her premedical course in 1986, followed by earning her Doctor of Medicine degree in 1990. Her passion for internal medicine and hematology led her to pursue advanced studies at The Catholic University of Korea, where she obtained a Master’s degree in 1998 and a Ph.D. in 2001. This strong academic background established her as a dedicated scholar committed to the advancement of medical sciences.

Professional Endeavors 🏥

Prof. Kim's professional career began with rigorous postdoctoral training. She completed her internship at St. Mary’s Hospital in 1991, followed by a residency in Internal Medicine at Catholic University Medical College until 1995. She further honed her expertise in hemato-oncology through a fellowship at Samsung Medical Center. Her international exposure expanded when she joined the Department of Microbiology and Immunology at IUPUI, USA, as a postdoctoral researcher. Her academic appointments at The Catholic University of Korea saw a steady rise, from Instructor in 1997 to Assistant Professor in 2001, Associate Professor in 2009, and finally attaining the prestigious title of Professor of Internal Medicine in 2014. In parallel, she has been a dedicated physician at St. Vincent Hospital since 1997 and has been leading the hematology and stem cell transplantation center since 2018.

Contributions and Research Focus 📝

Prof. Kim has made groundbreaking contributions in hematology and oncology, with a primary focus on stem cell transplantation, multiple myeloma, and lymphoma. Her extensive clinical trials and research studies have played a pivotal role in developing new treatment modalities for hematologic malignancies. Her work in targeted therapies, chemotherapy combinations, and immunotherapy has significantly improved patient outcomes and quality of life. She has been involved in more than 60 clinical trials, evaluating novel drug efficacy and safety, including studies on Zoledronic acid for multiple myeloma, targeted treatments like Dasatinib for leukemia, and the role of rituximab in lymphoma. Her research has also delved into prognostic factors, precision medicine, and innovative therapeutic strategies for refractory and relapsed hematologic diseases.

Accolades and Recognition 🏆

Prof. Kim's relentless pursuit of excellence has earned her recognition from esteemed medical institutions and societies. As a member of the Korean Association of Internal Medicine, the Korean Hematology Association, and the American Hematology Association, she has played an instrumental role in shaping global hematologic research. Her contributions have been acknowledged through numerous awards, invitations as a keynote speaker, and influential publications in high-impact medical journals.

Impact and Influence ✨

With a career spanning decades, Prof. Kim has mentored numerous young medical professionals, guiding them in clinical research and evidence-based medical practice. Her work has directly influenced hematologic treatment protocols in Korea and internationally. Her leadership in hematology and stem cell transplantation has set new benchmarks in patient care and innovative treatment approaches.

Legacy and Future Contributions 🌟

Prof. Jeong A Kim's legacy is deeply ingrained in the advancements of hematology and oncology. Her dedication to research, patient care, and education continues to inspire the next generation of medical professionals. Looking ahead, she remains committed to pioneering more targeted therapies, enhancing stem cell transplantation techniques, and improving long-term survival rates for hematologic malignancy patients. With ongoing research and collaborations, she is poised to make even greater strides in the field, leaving an indelible mark on medical science and patient care.

 

Publications

📄 The presence of clonal isotype switch after autologous stem cell transplantation as a prognostic biomarker for long-term survival in patients with multiple myeloma
Authors: H. Cho, J. Kim, Y. Park, Y. Kim, J. Kim, Jeong-ah
Journal: Leukemia Research
Year: 2025

📄 Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma
Authors: N.L. Bartlett, U.H. Hahn, W. Kim, F. Jie, J. Kim, Jeong-ah
Journal: Journal of Clinical Oncology
Year: 2025

📄 Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials
Authors: D. Shin, S. Park, E. Jang, W. Lee, D. Kim
Journal: Leukemia Research
Year: 2024

📄 Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study
Authors: H.Y. Yhim, Y. Park, J. Kim, Jeong-ah, D. Yang, J. Kwak
Journal: The Korean Journal of Internal Medicine
Year: 2024

Dong Hyun Kim | Medicine and Dentistry | Young Scientist Award

Published on by Book of Award

Dr. Dong Hyun Kim | Medicine and Dentistry | Young Scientist Award

Seoul National University College of Medicine | South Korea

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Dr. Dong Hyun Kim embarked on his medical journey at the prestigious Seoul National University College of Medicine, earning his Bachelor of Medicine in 2019. His academic rigor continued with a Master's degree in Medical Science, specializing in Translational Medicine, which he completed in 2024. His academic training laid the foundation for his future endeavors in clinical oncology and hematologic malignancies, blending medicine with cutting-edge research.

Professional Endeavors 🏥

Dr. Kim's professional career began at Seoul National University Hospital, where he completed his internship and then advanced to a Resident Doctor position in the Department of Internal Medicine. His expertise expanded into the field of Hemato-Oncology, where he currently serves as an External Clinical Researcher. His clinical work, especially in the realm of cancer treatment and translational medicine, has contributed significantly to patient care and scientific discovery.

Contributions and Research Focus 🔬

Dr. Kim’s research has made a considerable impact on hematologic malignancies and the use of artificial intelligence in oncology. His work spans various domains, including allogeneic stem cell transplantation, tumor-infiltrating lymphocytes as biomarkers, and predictive modeling in cancer treatment. Through his numerous publications, he has explored innovative treatments and personalized medicine, particularly focusing on improving patient outcomes in myelofibrosis, thymic epithelial neoplasms, and head and neck squamous cell carcinoma.

Accolades and Recognition 🏅

Dr. Kim has received numerous awards that underscore his contributions to the field. He earned the Best Oral Presentation Award at ICBMT 2022, a Presidential Oral Presentation at JSMO 2024, and another Best Oral Presentation Award at ICKSH 2024. These recognitions reflect his leadership in oncology research and his ability to present complex ideas with clarity and authority.

Impact and Influence 🌍

Through his published works, Dr. Kim has influenced the global oncology community. His research on artificial intelligence in oncology, predictive biomarkers, and innovative therapeutic approaches has opened new pathways in cancer treatment. His contributions, especially in improving treatment strategies for hematologic malignancies and solid tumors, are helping shape the future of personalized medicine.

Legacy and Future Contributions 🌟

Dr. Kim is poised to continue influencing the fields of clinical oncology and translational medicine. His dedication to research, combined with his clinical expertise, ensures that he will remain a key figure in advancing cancer treatment and improving patient outcomes. His future endeavors, backed by a solid academic and professional foundation, are expected to further elevate the standards of oncological care and research.

Publications

📄 Dual T-cell depletion with individually tailored anti-thymocyte globulin and attenuated dose of post-transplant cyclophosphamide in haploidentical peripheral stem cell transplantation
Author: Kim, D.H., Shin, D.-Y., Koh, Y., Byun, J.M., Hong, J.
Journal: Scientific Reports
Year: 2024

📄 Effects of tertiary palliative care on the pattern of end-of-life care in patients with hematologic malignancies in Korea
Author: Kim, D.H., Youk, J., Byun, J.M., Yoo, S.H., Shin, D.-Y.
Journal: European Journal of Haematology
Year: 2024

📄 Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study
Author: Kim, D.H., Lim, S.T., Kim, H.R., Shin, S.-H., Yun, H.J.
Journal: Oral Oncology
Year: 2024

📄 Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma
Author: Kim, D.H., Lim, Y., Ock, C.-Y., Kim, S.-B., Keam, B.
Journal: Head and Neck
Year: 2023